Pooja Sharma - 16 Apr 2026 Form 3 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
24 Apr 2026, 16:19:18 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Stone, Attorney-in-Fact for Pooja Sharma

Key filing fact

Pooja Sharma filed Form 3 for PROCEPT BioRobotics Corp (PRCT) on 24 Apr 2026.

Key facts

  • This page summarizes Pooja Sharma's Form 3 filing for PROCEPT BioRobotics Corp (PRCT).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 24 Apr 2026, 16:19.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002131636 Primary reporting owner

Sharma Pooja

Relationship
Chief Strat/Marketing Officer
Address
150 BAYTECH DR, SAN JOSE
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Pooja Sharma
Signature date
23 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
87,559
Date
16 Apr 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
85,929
Exercise price
$31.92
Footnotes
F2
PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
29,615
Exercise price
$25.35
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These securities include restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on the anniversary of the grant date, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date.

Footnote F2

The Stock Option was granted on November 7, 2025, and one-quarter of the shares subject to the Stock Option shall vest on November 7, 2026, with the remaining vesting monthly thereafter over 36 months, subject to the Reporting Person continuing as a service provider through such date.

Footnote F3

The Stock Option was granted on March 5, 2026, and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .